During the past decade, MUSC- Rutledge Tower conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MUSC- Rutledge Tower" are "Lumbar Spinal Stenosis" (1 trials) and "Squamous Cell Carcinoma of the Head and Neck" (1 trials). Many other conditions were trialed in "MUSC- Rutledge Tower" in a lesser frequency.

Most popular intervention types in "MUSC- Rutledge Tower" are "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "Chemoradiation" (1 trials) and "MILD" (1 trials). Other intervention names were less common.

The vast majority of trials in "MUSC- Rutledge Tower" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MUSC- Rutledge Tower". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MUSC- Rutledge Tower, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MUSC- Rutledge Tower, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".